Mark Page

2.5k citations

71 papers · 1.2k indexed · h-index 19

Co-authors: Neil Almond Kingston H. G. Mills Giada Mattiuzzo P. Kitchin Martin Cranage E. J. Stott F. Taffs Philip D. Minor
Topics: HIV Research and Treatment (26 papers)Viral Infections and Outbreaks Research (12 papers)Hepatitis B Virus Studies (11 papers)
Cited by: Virology Infectious Diseases Immunology
Journals: The LancetSHILAP Revista de lepidopterologíaNature Biotechnology
Partner nations: United Kingdom United States Netherlands

In The Last Decade

Mark Page

69 papers receiving 1.2k citations

Peers

Countries citing papers authored by Mark Page

Since Specialization

Citations

This map shows the geographic impact of Mark Page's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Page with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Page more than expected).

Fields of papers citing papers by Mark Page

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Page. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Page. The network helps show where Mark Page may publish in the future.

Co-authorship network of co-authors of Mark Page

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Page. A scholar is included among the top collaborators of Mark Page based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Page. Mark Page is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	VelcroVax: a “Bolt-On” Vaccine Platform for Glycoprotein Display 2023 ·mSphere ·(unknown),Keith Grehan,(unknown),Mark Hassall,(unknown),Guido C. Paesen,Lee Sherry,(unknown),Amy L. Roe,Sam L. Stephen,Darren C. Tomlinson,Antra Zeltina,Katie J. Doores,Neil A. Ranson,Martin Stacey,Mark Page,Nicola J. Rose,Thomas A. Bowden,David J. Rowlands,Nicola J. Stonehouse	3
2	Passive immunisation of convalescent human anti-Zika plasma protects against challenge with New World Zika virus in cynomolgus macaques 2020 ·npj Vaccines ·Neil Berry,Sarah Kempster,Claire Ham,Adrian Jenkins,(unknown),Mark Page,Giada Mattiuzzo,(unknown),Roger Hewson,(unknown),(unknown),Neil Almond	7
3	Towards quantification of protective antibody responses by passive transfer of the 1st WHO International Standard for Ebola virus antibody in a guinea pig model 2019 ·Vaccine ·Stuart Dowall,Sarah Kempster,Stephen Findlay‐Wilson,Giada Mattiuzzo,Victoria Graham,Mark Page,Roger Hewson,Neil Almond	3
4	Complement-Mediated Virus Infectivity Neutralisation by HLA Antibodies Is Associated with Sterilising Immunity to SIV Challenge in the Macaque Model for HIV/AIDS 2014 ·PLoS ONE ·Mark Page,Ruby Quartey‐Papafio,Mark W. Robinson,Mark Hassall,Martin Cranage,(unknown),Neil Almond	10
5	Heterologous protection elicited by candidate monomeric recombinant HIV-1 gp120 vaccine in the absence of cross neutralising antibodies in a macaque model 2012 ·Retrovirology ·Mark Page,Richard Stebbings,Neil Berry,Robin Hull,David Ferguson,(unknown),(unknown),(unknown),Joanna Hall,Claire Ham,Mark Hassall,Bo Li,Edward Mee,Ruby Quartey‐Papafio,Nicola J. Rose,Nathalie Mathy,Gérald Voss,E. J. Stott,Neil Almond	4
6	Early Potent Protection against Heterologous SIVsmE660 Challenge Following Live Attenuated SIV Vaccination in Mauritian Cynomolgus Macaques 2011 ·PLoS ONE ·Neil Berry,Claire Ham,Edward Mee,Nicola J. Rose,Giada Mattiuzzo,Adrian Jenkins,Mark Page,(unknown),Mark W. Robinson,Deborah F. Smith,David Ferguson,Greg J. Towers,Neil Almond,Richard Stebbings	20
7	Vaccination with live attenuated simian immunodeficiency virus causes dynamic changes in intestinal CD4+CCR5+ T cells 2011 ·Retrovirology ·Bo Li,Neil Berry,Claire Ham,David Ferguson,(unknown),Joanna Hall,Mark Page,Ruby Quartey‐Papafio,(unknown),Mark W. Robinson,Neil Almond,Richard Stebbings	6
8	Mhc haplotype M3 is associated with early control of SHIVsbg infection in Mauritian cynomolgus macaques 2010 ·Tissue Antigens ·Edward Mee,Neil Berry,Claire Ham,A.M. Aubertin,(unknown),(unknown),Richard Stebbings,Mark Page,Neil Almond,Nicola J. Rose	17
9	A Sensitive Cell-Based Assay to Measure the Doxycycline Concentration in Biological Samples 2009 ·Human Gene Therapy ·Wendy Kleibeuker,Xue Zhou,Mireille Centlivre,Nicolas Legrand,Mark Page,Neil Almond,Ben Berkhout,Atze T. Das	18
10	Anti-MRSA β-lactams in development 2006 ·Current Opinion in Pharmacology ·Mark Page	42
11	Preparation of Purified Immunoglobulin G (IgG) 2003 ·Humana Press eBooks ·Mark Page,(unknown),Robin Thorpe	1
12	A history of the county of Northampton 2002 ·(unknown),(unknown),Mark Page,(unknown)	3
13	Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers 2002 ·Vaccine ·Maria–Christina Jung,Norbert H. Grüner,Roman Zachoval,Winfried Schraut,Tilman Gerlach,Helmut M. Diepolder,(unknown),Mark Page,(unknown),(unknown),E. Douglas Whitehead,Jörg Trojan,Stefan Zeuzem,Gerd R. Pape	55
14	A Novel, Recombinant Triple Antigen Hepatitis B Vaccine (Hepacare<sup>®</sup>) 2001 ·Intervirology ·Mark Page,Chris Jones,(unknown)	12
15	T-cell and antibody response characterisation of a new recombinant pre-S1, pre-S2 and SHBs antigen-containing hepatitis B vaccine; demonstration of superior anti-SHBs antibody induction in responder mice 1999 ·Vaccine ·Chris Jones,Mark Page,Andrew Bacon,(unknown),Matthew G. Bentley,Steven N. Chatfield	27
16	Characterization of the T‐ and B‐cell immune response to a new recombinant pre‐S1, pre‐S2 and SHBs antigen containing hepatitis B vaccine (Hepagene™); evidence for superior anti‐SHBs antibody induction in responder mice 1998 ·Journal of Viral Hepatitis ·Chris Jones,Mark Page,Andrew Bacon,(unknown),Matthew G. Bentley,S Chatfield	14
17	Passive Immunization of Cynomolgus Macaques with Immune Sera or a Pool of Neutralizing Monoclonal Antibodies Failed to Protect Against Challenge with SIVmac251 1994 ·AIDS Research and Human Retroviruses ·Karen A. Kent,P. Kitchin,Kingston H. G. Mills,Mark Page,F. Taffs,T. Corcoran,P. Silvera,Brian Flanagan,(unknown),Jane Rose,(unknown),A.‐M. Aubertin,E. J. Stott	46
18	Vaccine Studies With the ³² H Reisolate of SIV _mac251 : An Overview 1992 ·AIDS Research and Human Retroviruses ·Martin Cranage,Jim Stott,Kingston H. G. Mills,(unknown),F. Taffs,Graham H. Farrar,Ling Ling Chan,(unknown),Per Putkonen,Gunnel Biberfeld,Michael Murphey‐Corb,Mark Page,A. Baskerville,(unknown),Peter Greenaway	15
19	Studies on the immunogenicity of chinese hamster ovary cell-derived recombinant gp120 (HIV-1IIIB) 1991 ·Vaccine ·Mark Page,Kingston H. G. Mills,G. C. Schild,(unknown),Vainav Patel,Áine McKnight,(unknown),Paula Dilger,Robin Thorpe	8
20	Preliminary report: protection of cynomolgus macaques against simian immunodeficiency virus by fixed infected-cell vaccine 1990 ·The Lancet ·E. J. Stott,F. Taffs,P. Kitchin,Woon Ling Chan,Kingston H. G. Mills,Mark Page,Martin Cranage,P. J. Greenaway	142

About Mark Page

Mark Page is a scholar working on Virology, Infectious Diseases and Immunology, having authored 71 papers that have together received 1.2k indexed citations. Recurring topics across this work include HIV Research and Treatment (26 papers), Viral Infections and Outbreaks Research (12 papers) and Hepatitis B Virus Studies (11 papers). The work is most often cited by research in Virology (505 citations), Infectious Diseases (436 citations) and Immunology (395 citations). Mark Page has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Neil Almond, Kingston H. G. Mills, Giada Mattiuzzo, P. Kitchin, Martin Cranage, E. J. Stott, F. Taffs, Philip D. Minor, Andrew F. Rowley and Woon Ling Chan. Their work appears in journals such as The Lancet, SHILAP Revista de lepidopterología and Nature Biotechnology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact